DENBURY INC. Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 17 rows, 17 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-09-06: Reporting owner ALLEN MARK C; Form 4; Security Series B Warrants (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2023-08-29: Reporting owner Sheppard David E; Form 4; Security Series B Warrants (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2023-08-29: Reporting owner ALLEN MARK C; Form 4; Security Series B Warrants (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2023-08-29: Reporting owner Kendall Christian S; Form 4; Security Series B Warrants (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-09-06 | ALLEN MARK C Officer (Executive VP & CFO) | 4 | Series B Warrants (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,299 0 owned after | $35.41 exercise price | 2023-09-08 | |
| 2023-08-29 | Sheppard David E Officer (EVP and COO) | 4 | Series B Warrants (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −347 0 owned after | $35.41 exercise price | 2023-08-31 | |
| 2023-08-29 | ALLEN MARK C Officer (Executive VP & CFO) | 4 | Series B Warrants (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,298 1,299 owned after | $35.41 exercise price | 2023-08-31 | |
| 2023-08-29 | Kendall Christian S Director, Officer (President and CEO) | 4 | Series B Warrants (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,568 0 owned after | $35.41 exercise price | 2023-08-31 | |
| 2023-08-22 | Matthews James S. Officer (EVP, CAO, GC & Sec'y) | 4 | Series B Warrants (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,041 0 owned after | $35.41 exercise price | 2023-08-24 | |
| 2023-08-07 | Meyers Kevin Omar Director | 4 | Series B Warrants (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −748 0 owned after | $35.41 exercise price | 2023-08-09 | |
| 2023-03-13 | Jennings Nicole H. Officer (Vice President and CAO) | 4 | Series B Warrants (Right to Buy) Derivative · Direct | S Open market or private sale of non-derivative or derivative security | −103 0 owned after | $44.93 | 2023-03-15 | |
| 2023-03-02 | Peterson Lynn A Director | 4 | Series B Warrants (Right to Buy) Derivative · Direct | S Open market or private sale of non-derivative or derivative security | −186 284 owned after | $48.81 | 2023-03-03 | |
| 2022-06-06 holding as of filing | Sheppard David E Officer (EVP and COO) | 3 | Series B Warrants (Right to Buy) Derivative · Direct | Holding | $35.41 exercise price | 2022-06-06 | ||
| 2021-01-19 holding as of filing | Jennings Nicole H. Officer (Vice President and CAO) | 3 | Series B Warrants (Right to Buy) Derivative · Direct | Holding | $35.41 exercise price | 2021-01-19 | ||
| 2020-11-19 | Rhoades Alan Officer (VP & Chief Accounting Officer) | 4 | Series B Warrants (Right to Buy) Derivative · Direct | S Open market or private sale of non-derivative or derivative security | −924 26 owned after | $1.90 | 2020-11-23 | |
| 2020-09-18 | Peterson Lynn A Director | 4 | Series B Warrants (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +470 470 owned after | $35.41 exercise price | 2020-09-22 | |
| 2020-09-18 | Meyers Kevin Omar Director | 4 | Series B Warrants (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +748 748 owned after | $35.41 exercise price | 2020-09-22 | |
| 2020-09-18 | Rhoades Alan Officer (VP & Chief Accounting Officer) | 4 | Series B Warrants (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +952 952 owned after | $35.41 exercise price | 2020-09-22 | |
| 2020-09-18 | Matthews James S. Officer (EVP, CAO, GC & Sec'y) | 4 | Series B Warrants (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,041 1,041 owned after | $35.41 exercise price | 2020-09-22 | |
| 2020-09-18 | ALLEN MARK C Officer (Executive VP & CFO) | 4 | Series B Warrants (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,953 2,953 owned after | $35.41 exercise price | 2020-09-22 | |
| 2020-09-18 | Kendall Christian S Director, Officer (President and CEO) | 4 | Series B Warrants (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,569 3,569 owned after | $35.41 exercise price | 2020-09-22 |